Enliven Therapeutics
ELVNInsider trades and stock quote 2023-2025
All insider trades at Enliven Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 10/7/2025 | Sell | Patel, Anish | CHIEF OPERATING OFFICER | $20.1 | $133,993 |
| 9/29/2025 | Sell | Hohl, Benjamin | CHIEF FINANCIAL OFFICER | $20.4 | $66,291 |
| 9/26/2025 | Sell | Lyssikatos, Joseph P. | CHIEF SCIENTIFIC OFFICER | $20.3 | $81,005 |
| 9/26/2025 | Sell | Kintz, Samuel | PRESIDENT AND CEO | $20.1 | $74,228 |
| 9/23/2025 | Sell | Lyssikatos, Joseph P. | CHIEF SCIENTIFIC OFFICER | $20.0 | $30,045 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)